Neurobiological mechanisms of nicotine reward and aversion

L Wills, JL Ables, KM Braunscheidel… - Pharmacological …, 2022 - Elsevier
Neuronal nicotinic acetylcholine receptors (nAChRs) regulate the rewarding actions of
nicotine contained in tobacco that establish and maintain the smoking habit. nAChRs also …

Neural circuits and nicotinic acetylcholine receptors mediate the cholinergic regulation of midbrain dopaminergic neurons and nicotine dependence

C Xiao, C Zhou, J Jiang, C Yin - Acta Pharmacologica Sinica, 2020 - nature.com
Midbrain dopaminergic (DA) neurons are governed by an endogenous cholinergic system,
originated in the mesopontine nuclei. Nicotine hijacks nicotinic acetylcholine receptors …

Nicotine aversion is mediated by GABAergic interpeduncular nucleus inputs to laterodorsal tegmentum

SL Wolfman, DF Gill, F Bogdanic, K Long… - Nature …, 2018 - nature.com
Nicotine use can lead to dependence through complex processes that are regulated by both
its rewarding and aversive effects. Recent studies show that aversive nicotine doses activate …

β2* nAChRs on VTA dopamine and GABA neurons separately mediate nicotine aversion and reward

TE Grieder, M Besson, G Maal-Bared… - Proceedings of the …, 2019 - National Acad Sciences
Evidence shows that the neurotransmitter dopamine mediates the rewarding effects of
nicotine and other drugs of abuse, while nondopaminergic neural substrates mediate the …

[HTML][HTML] Enhancing translation: A need to leverage complex preclinical models of addictive drugs to accelerate substance use treatment options

C Corley, A Craig, S Sadek, JA Marusich… - Pharmacology …, 2024 - Elsevier
Preclinical models of addictive drugs have been developed for decades to model aspects of
the clinical experience in substance use disorders (SUDs). These include passive exposure …

Chrna5-expressing neurons in the interpeduncular nucleus mediate aversion primed by prior stimulation or nicotine exposure

G Morton, N Nasirova, DW Sparks… - Journal of …, 2018 - Soc Neuroscience
Genetic studies have shown an association between smoking and variation at the
CHRNA5/A3/B4 gene locus encoding the α5, α3, and β4 nicotinic receptor subunits. The α5 …

New insights on the effects of varenicline on nicotine reward, withdrawal and hyperalgesia in mice

D Bagdas, Y Alkhlaif, A Jackson, FI Carroll, JW Ditre… - …, 2018 - Elsevier
Varenicline, a partial agonist for α4β2* nicotinic acetylcholine receptors (nAChRs) and a full
agonist for α3β4 and α7 nAChRs, is approved for smoking cessation treatment. Although …

SR9883 is a novel small-molecule enhancer of α4β2* nicotinic acetylcholine receptor signaling that decreases intravenous nicotine self-administration in rats

KM Braunscheidel, G Voren, CD Fowler… - Frontiers in Molecular …, 2024 - frontiersin.org
Background Most smokers attempting to quit will quickly relapse to tobacco use even when
treated with the most efficacious smoking cessation agents currently available. This …

Mouse strain-specific acute respiratory effects of nicotine unrelated to nicotine metabolism

AJ Bloom - Toxicology mechanisms and methods, 2019 - Taylor & Francis
Plethysmograph measurement of respiratory phenotypes provides a highly sensitive means
to study nicotine response in experimental model animals. We measured average …

Interactive effects of ARRB2 and CHRNA5 genetic polymorphisms on cognitive function in Chinese male methamphetamine use disorder patients

L Jiang, D Wang, Y Tian, J Chen, M Qu… - The American Journal … - Wiley Online Library
Abstract Background and Objectives Both β‐arrestin2 and nicotinic acetylcholine receptor
(nAChR) have been implicated in cognitive processes, particularly in relation to psychiatric …